1 Min Read
Oct 11 (Reuters) - T. Rowe Price Associates Inc:
* T. Rowe Price Associates Inc reports 14.4 percent passive stake in Aquinox Pharmaceuticals Inc as of sept. 30 - SEC filing Source text (bit.ly/2dSIWc7) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.